Lactobacillus Bacteremia in a Critically Ill Patient

Mohamed Saad Eldin^1, , Sadaquat Liaqat¹, Khaled Awad¹ and Salah Aldergash¹

¹Department of Internal Medicine, Conemaugh Memorial Medical Center, Johnstown, PA, USA

Cite this paper

Mohamed Saad Eldin, Sadaquat Liaqat, Khaled Awad and Salah Aldergash. Lactobacillus Bacteremia in a Critically Ill Patient. American Journal of Medical Case Reports. 2019; 7(9):191-192. doi: 10.12691/AJMCR-7-9-2

Abstract

Lactobacilli are normal commensal bacteria of human. They can cause fatal infections in an immunocompromised host. We present a case of an immunocompromised patient with stage IV non-small cell lung cancer receiving Nivolumab who had high grade lactobacillus bacteremia and fungal blood stream infection.

Keywords

lactobacilli, Nivolumab, lactobacillus acidophilus

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Goldstein EJC, Tyrrell KL, Citron DM. Lactobacillus species: taxonomic complexity and controversial susceptibilities. Clin Infect Dis. 2015;60(suppl 2):S98-S107.
[2]	Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis. 2004; 38: 62-69.
[3]	Gouriet F, Million M, Henri M, Fournier PE, Raoult D. Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur J Clin Microbiol Infect Dis. 2012; 31: 2469-2480.
[4]	Harty DW, Oakey HJ, Patrikakis M, Hume EB, Knox KW. Pathogenic potential of lactobacilli. Int J Food Microbiol. 1994; 24: 179-189.
[5]	Kulkarni HS, Khoury CC. Sepsis associated with Lactobacillus bacteremia in a patient with ischemic colitis. Indian J Crit Care Med. 2014; 18: 606-608.
[6]	Meini S, Laureano R, Fani L, et al. Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature. Infection. 2015; 43: 777-781.
[7]	Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis. 2005; 24: 31-40.
[8]	Kyriacou A, Tsimpidi E, Kazantzi E, et al. Microbial content and antibiotic susceptibility of bacterial isolates from yoghurts. Int J Food Sci Nutr. 2008; 59: 512-525.
[9]	Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis. 2006; 42: e35-e44.
[10]	Monterisi A, Dain AA, Suárez de, Basnec MC, Roca G, Trucchia R, Bantar C. Native-valve endocarditis produced by Lactobacillus casei sub. rhamnosus refractory to antimicrobial therapy [in Spanish]. Medicina (B Aires). 1996; 56: 284-286.